Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts
Sofia Vrettou, Sebastian Zetzsche, Brunhilde Wirth
This study shows that OMAV increases NRF2 target proteins in SMA type I fibroblasts, suggesting potential cytoprotective effects.
The FASEB Journal · Jun 16, 2026Peer-reviewedCell Biology